Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
miR-508 overexpression
i
Other names:
MIR508, MicroRNA 508, Hsa-MiR-508-5p, Hsa-Mir-508, MIRN508
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
574513
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
miR-508 overexpression
Non Small Cell Lung Cancer
miR-508 overexpression
Non Small Cell Lung Cancer
nivolumab
Sensitive: D – Preclinical
nivolumab
Sensitive
:
D
nivolumab
Sensitive: D – Preclinical
nivolumab
Sensitive
:
D
miR-508 overexpression
Non Small Cell Lung Cancer
miR-508 overexpression
Non Small Cell Lung Cancer
pembrolizumab
Sensitive: D – Preclinical
pembrolizumab
Sensitive
:
D
pembrolizumab
Sensitive: D – Preclinical
pembrolizumab
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.